Success Metrics

Clinical Success Rate
85.0%

Based on 17 completed trials

Completion Rate
85%(17/20)
Active Trials
5(14%)
Results Posted
71%(12 trials)
Terminated
3(9%)

Phase Distribution

Ph phase_3
2
6%
Ph phase_1
10
29%
Ph phase_4
11
31%
Ph not_applicable
6
17%
Ph phase_2
6
17%

Phase Distribution

10

Early Stage

6

Mid Stage

13

Late Stage

Phase Distribution35 total trials
Phase 1Safety & dosage
10(28.6%)
Phase 2Efficacy & side effects
6(17.1%)
Phase 3Large-scale testing
2(5.7%)
Phase 4Post-market surveillance
11(31.4%)
N/ANon-phased studies
6(17.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

73.9%

17 of 23 finished

Non-Completion Rate

26.1%

6 ended early

Currently Active

5

trials recruiting

Total Trials

35

all time

Status Distribution
Active(8)
Completed(17)
Terminated(6)
Other(4)

Detailed Status

Completed17
Recruiting4
unknown4
Enrolling by invitation3
Withdrawn3
Terminated3

Development Timeline

Analytics

Development Status

Total Trials
35
Active
5
Success Rate
85.0%
Most Advanced
Phase 4

Trials by Phase

Phase 110 (28.6%)
Phase 26 (17.1%)
Phase 32 (5.7%)
Phase 411 (31.4%)
N/A6 (17.1%)

Trials by Status

enrolling_by_invitation39%
withdrawn39%
completed1749%
active_not_recruiting13%
recruiting411%
terminated39%
unknown411%

Recent Activity

5 active trials
Showing 5 of 35
recruitingphase_2

Effects of Treatments on Atopic Dermatitis

NCT01631617
recruitingphase_1

The Effect of Losartan on Cephalexin

NCT07300670
active_not_recruitingphase_4

Utility of Single-dose Oral Antibiotic Prophylaxis in Prevention of Surgical Site Infection in Dermatologic Surgery

NCT04580472
recruitingphase_2

Microbiome and Association With Implant Infections

NCT05020574
withdrawnphase_4

Role of Prophylactic Postoperative Antibiotics in HoLEP

NCT05274672
View all 35 trials

Clinical Trials (35)

Showing 20 of 35 trialsScroll for more
NCT01631617Phase 2

Effects of Treatments on Atopic Dermatitis

Recruiting
NCT07300670Phase 1

The Effect of Losartan on Cephalexin

Recruiting
NCT04580472Phase 4

Utility of Single-dose Oral Antibiotic Prophylaxis in Prevention of Surgical Site Infection in Dermatologic Surgery

Active Not Recruiting
NCT05020574Phase 2

Microbiome and Association With Implant Infections

Recruiting
NCT05274672Phase 4

Role of Prophylactic Postoperative Antibiotics in HoLEP

Withdrawn
NCT06055712Phase 4

Antibiotic Prophylaxis in Pediatric Open Fractures

Enrolling By Invitation
NCT05852262Phase 4

High-dose Cephalexin for Cellulitis (HI-DOCC)

Enrolling By Invitation
NCT06127160Phase 4

Patient-Directed Antimicrobial Duration in Acute Uncomplicated Pyelonephritis

Completed
NCT04297592Phase 4

Antibiotic Prophylaxis in High-Risk Arthroplasty Patients

Enrolling By Invitation
NCT01912651Phase 4

The Role of Antibiotics in Full Thickness Skin Graft Survival for Facial Reconstructive Surgery

Recruiting
NCT04471246Phase 4

High-dose vs. Standard-dose Cephalexin for Cellulitis

Completed
NCT02014558Phase 1

Dose Escalation Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of ASP2215 in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Completed
NCT04916951Phase 1

Oral Amoxicillin and Cephalexin PK/PD in Neonates

Unknown
NCT03187106Phase 1

Prophylactic Antibiotics After Cesarean

Completed
NCT05664568Phase 2

The BLAST- 1 Trial - Cephalexin+Amoxicillin-clavulanate for Tuberculosis

Unknown
NCT04834310Phase 4

Postoperative Antibiotics Following Primary and Secondary Breast Augmentation

Withdrawn
NCT03357419Not Applicable

The Effect of Prophylactic Antibiotics on Surgical Site Infection Lower Limb Skin Excisions

Withdrawn
NCT04553419Phase 3

Antibiotic Treatment Of Staphylococcus Aureus In Stable People With CF

Unknown
NCT03802552Phase 1

Cefadroxil and Cephalexin Drug Levels and Dosing in Pediatric Musculoskeletal Infections

Completed
NCT01595529Phase 2

The SCOUT Study: "Short Course Therapy for Urinary Tract Infections in Children"

Completed

Drug Details

Intervention Type
DRUG
Total Trials
35